Mutations in beta-hexosaminidase beta-subunit gene and the clinical phenotypes
β-己糖胺酶β亚基基因突变与临床表型
基本信息
- 批准号:08670905
- 负责人:
- 金额:$ 1.22万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Four unrelated japanese Patients with infantile Sandhoff disease (beta-hexosaminidase beta-subunit deficiency) have been studied for their molecular basis of their severe phenotype. Two patients had complex base substitutions ; one patient was homoallelic for a triple mutation (P417L,K121R and S255R) and the other was a compound heterozygote of a double (P417L and K121R) mutation and the triple mutation. K121R has been known to be a functional polymorphisms, while P417L (exon 11, +8 C*T) generates predominantly an abnormally spliced mRNA at +112 base of exon 11 and has been described in two patients with a juvenile form of the disease. The mild phenotype is attributed to the presence of a small amount of normally spliced mRNA.S255R is novel without prior description in the literature. An expression study of the normally spliced cDNA with the double and the triple mutations gave 78% and 28% of normal activity, respectively. This finding suggested that S255R further reduces the catalytic … More activity of the already below-the threshold amount of normally spliced mRNA and accounts for the more severe phenotype in our patients. In the other two patients a novel disease-causing base transition was found within intron 10, away from the intron/exon junction (-17 a*g). This mutation caused abnormal 3' splicing at-37 of intron 10, and normally spliced product was detectable in RT-PCR analysis. We noted an unusually low splice site score (61.8) for the exon 10-intron 11 junction and suspected that this might be partially responsible for these abberant splicing in these mutations. To test this hypothesis, we constructed four chimeric cDNAs all with additinal intron 10 inserted and evaluated their splicing efficiency. They respectively had the normal sequence, P417L (exon 11, +8 C*T), the intronic mutation (-17 a*g), and an artificially engineered intron 10-exon 11 junction with a higher splice site score (85.1). Fifty-eight % and 31% of total transcript were correctly spliced in the normal chimeric construct and P417L,respectively, while no normally spliced product was generated either in the chimeric construct with -17 a*g or in that with a high splice site score. The sequence around the adenosine 17 residues upstream of the normal acceptor splice site in this report UUGCAAU (-22 to -16) matches the consensus branchpoint sequence YNYRAY reported in the literature. The mutation in this study is most likely to abolish the lariat formation because the artificial site of high splice acore did not improve splicing efficiency. Less
研究了4例无亲缘关系的日本婴儿山德霍夫病(β-氨基己糖苷酶β-亚单位缺乏症),以了解其严重表型的分子基础。两名患者有复杂的碱基替换;一名患者是纯等位基因的三重突变(P417 L,K121 R和S255 R),另一个是复合杂合子的双重(P417 L和K121 R)突变和三重突变。已知K121 R是一种功能性多态性,而P417 L(外显子11,+8 C*T)主要在外显子11的+112碱基处产生异常剪接的mRNA,并已在两名患有幼年型疾病的患者中描述。S255 R是一种新的突变体,在文献中未见报道。正常剪接的cDNA与双和三重突变的表达研究给出了78%和28%的正常活动,分别。这一发现表明,S255 R进一步降低了 ...更多信息 已经低于正常剪接的mRNA的阈值量的活性,并解释了我们患者中更严重的表型。在另外两名患者中,在内含子10内发现了一种新的致病碱基转换,远离内含子/外显子连接(-17 a*g)。该突变导致内含子10的-37位点发生异常3'剪接,RT-PCR检测到正常剪接产物。我们注意到外显子10-内含子11连接处的剪接位点评分异常低(61.8),并怀疑这可能是这些突变中异常剪接的部分原因。为了验证这一假设,我们构建了四个嵌合cDNA,它们都插入了额外的内含子10,并评估了它们的剪接效率。它们分别具有正常序列、P417 L(外显子11,+8 C*T)、内含子突变(-17 a*g)和具有较高剪接位点评分(85.1)的人工工程化内含子10-外显子11连接。在正常嵌合构建体和P417 L中分别有58%和31%的总转录物被正确剪接,而在具有-17 a*g的嵌合构建体或具有高剪接位点评分的嵌合构建体中没有产生正常剪接的产物。本报告中正常受体剪接位点上游腺苷17个残基周围的序列UUGCAAU(-22至-16)与文献中报道的共有分支点序列YNYRAY匹配。本研究中的突变最有可能消除lactone的形成,因为高剪接acore的人工位点并没有提高剪接效率。少
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
田中 あけみ: "ガングリオシドーシス" 小児内科. 28・増刊. 373-378 (1996)
Akemi Tanaka:“神经节苷脂沉积症”小儿内科 28/特刊 373-378 (1996)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kobayashi T,Kuraoka I,Saijo M,Nakatsu Y,Tanaka A,Someda Y,Fukuro S and Tanaka K: "Mutations in the XPO gene leading to xeroderma pigmentosum symptoms" Human Mutation. 9. 322-331 (1997)
Kobayashi T、Kuraoka I、Saijo M、Nakatsu Y、Tanaka A、Someda Y、Fukuro S 和 Tanaka K:“XPO 基因突变导致着色性干皮病症状”人类突变。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tanaka A: "Gangliosidoses" Internal Pediatrics. 28. 373-378 (1996)
田中答:“神经节苷脂病”内科儿科。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tanaka A et.al.Chugai Igakusha: Tay-sachs disease Kensachi no mikata. Chugai Igakusha, 121-125 (1996)
Tanaka A et.al.Chugai Igakusha:泰萨克斯病 Kensachi no mikata。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kobayashi T,Kuraoka I,et.al: "Mutations in the XPD gene leading to xeroderma pigmentosum symptoms." Human Mutation. 9(4). 322-331 (1997)
Kobayashi T、Kuraoka I 等人:“XPD 基因突变导致色素性干皮病症状。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TANAKA Akemi其他文献
TANAKA Akemi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TANAKA Akemi', 18)}}的其他基金
Experimental study for the treatment of neuronal degeneration in lysosomal storage diseases by modification of autophagy
修饰自噬治疗溶酶体贮积症神经元变性的实验研究
- 批准号:
23591511 - 财政年份:2011
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Experimental study of immune responses in cell transplantation therapy for genetic neurodegenerative disorders
细胞移植治疗遗传性神经退行性疾病免疫反应的实验研究
- 批准号:
20591229 - 财政年份:2008
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Effect of Cell Fusion with the Host Brain Cells on the Neuronal Differentiation of Transplanted Mesenchymal Stem Cells in the Brain
细胞与宿主脑细胞融合对脑内移植间充质干细胞神经元分化的影响
- 批准号:
18591163 - 财政年份:2006
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishing of cell strain from mouse ES cells for the therapeutic use and study in neurodegenerative disorders
从小鼠 ES 细胞中建立细胞株,用于神经退行性疾病的治疗和研究
- 批准号:
15591125 - 财政年份:2003
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Gene Therapy for Genetic Neurodegenerative Disorders by Cultured Microglia Cell for Gene Delivery
通过培养小胶质细胞进行基因传递治疗遗传性神经退行性疾病
- 批准号:
11694306 - 财政年份:1999
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (A).
Targetting of the brain by cultured microglia cell for neurofrgenerative disorders.
通过培养的小胶质细胞靶向大脑治疗神经再生障碍。
- 批准号:
11557060 - 财政年份:1999
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The enzyme activity sites and the conjugation sites for dimers formation in hexosaminidase S (α α) and B (ββ)
氨基己糖苷酶 S (α α) 和 B (ββ) 中形成二聚体的酶活性位点和结合位点
- 批准号:
10670750 - 财政年份:1998
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies of Gene Abnormalities, Protein Abnormalities, and Their Phenotypes in Lysosomal Diseases.
溶酶体疾病中基因异常、蛋白质异常及其表型的研究。
- 批准号:
06670818 - 财政年份:1994
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Development of a new biomarker of GM2 gangliosidosis
GM2 神经节苷脂沉积症新生物标志物的开发
- 批准号:
23659527 - 财政年份:2011
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
GM2 Gangliosidosis Therapy Using Neurotropic Enzyme
使用神经营养酶治疗 GM2 神经节苷脂沉积症
- 批准号:
7897875 - 财政年份:2009
- 资助金额:
$ 1.22万 - 项目类别:
Neuro-inflammation and treatment in GM2 gangliosidosis
GM2 神经节苷脂沉积症的神经炎症和治疗
- 批准号:
7193508 - 财政年份:2004
- 资助金额:
$ 1.22万 - 项目类别:
Neuro-inflammation and treatment in GM2 gangliosidosis
GM2 神经节苷脂沉积症的神经炎症和治疗
- 批准号:
7022218 - 财政年份:2004
- 资助金额:
$ 1.22万 - 项目类别:
Neuro-inflammation and treatment in GM2 gangliosidosis
GM2 神经节苷脂沉积症的神经炎症和治疗
- 批准号:
7814736 - 财政年份:2004
- 资助金额:
$ 1.22万 - 项目类别:
Neuro-inflammation and treatment in GM2 gangliosidosis
GM2 神经节苷脂沉积症的神经炎症和治疗
- 批准号:
6849742 - 财政年份:2004
- 资助金额:
$ 1.22万 - 项目类别:
Neuro-inflammation and treatment in GM2 gangliosidosis
GM2 神经节苷脂沉积症的神经炎症和治疗
- 批准号:
6765522 - 财政年份:2004
- 资助金额:
$ 1.22万 - 项目类别:
GM2 GANGLIOSIDOSIS--MOLECULAR GENETICS & THERAPY
GM2 神经节苷脂症--分子遗传学
- 批准号:
2135762 - 财政年份:1994
- 资助金额:
$ 1.22万 - 项目类别:
FELINE GM2 GANGLIOSIDOSIS--MOLECULAR GENETICS & THERAPY
猫科动物 GM2 神经节瘤病--分子遗传学
- 批准号:
2135761 - 财政年份:1993
- 资助金额:
$ 1.22万 - 项目类别:
PATHOGENESIS AND GENE THERAPY IN GM2-GANGLIOSIDOSIS
GM2 神经节节病的发病机制和基因治疗
- 批准号:
3414165 - 财政年份:1990
- 资助金额:
$ 1.22万 - 项目类别:














{{item.name}}会员




